Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuki Gosei Kogyo Co., Ltd. (4531:JPX), powered by AI.
Yuki Gosei Kogyo Co., Ltd. is currently trading at ¥335. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Yuki Gosei Kogyo Co., Ltd. on Alpha Lenz.
Yuki Gosei Kogyo Co., Ltd.'s P/E ratio is 8.1.
“Yuki Gosei Kogyo Co., Ltd. trades at a P/E of 8.1 (undervalued) with modest ROE of 7.0%.”
Ask for details →Yuki Gosei Kogyo Co., Ltd. is a Japanese chemical manufacturing company known for its extensive range of chemical products. The company's primary function lies in the development and production of fine chemicals, pharmaceutical intermediates, and specialty chemicals used across various industries. Notable for its role in the pharmaceutical sector, Yuki Gosei Kogyo Co., Ltd. supplies key chemical intermediates that are crucial for the synthesis of active pharmaceutical ingredients (APIs). Furthermore, the company is involved in producing chemicals that serve the electronics industry, contributing materials used in semiconductor and display technologies. Founded in 1947 and headquartered in Tokyo, Japan, Yuki Gosei Kogyo has established itself as a significant player in the chemical industry through innovation and a focus on meeting the stringent quality demands of its diverse clientele. Its operations are pivotal in supporting the supply chain of industries ranging from healthcare to electronics, marking its influence on both domestic and international markets.
“Yuki Gosei Kogyo Co., Ltd. trades at a P/E of 8.1 (undervalued) with modest ROE of 7.0%.”
Ask for details →Yuki Gosei Kogyo Co., Ltd. (ticker: 4531) is a company listed on JPX in the Basic Materials sector (Chemicals). It has approximately 296 employees. Market cap is $7.3B.
The current price is 335 with a P/E ratio of 8.1x and P/B of 0.55x.
ROE is 7.02% and operating margin is 8.06%. Annual revenue is $15.1B.